These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17295682)

  • 1. Expression of neuroendocrine markers in non-small cell lung cancer.
    Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
    APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
    Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
    Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A gene expression in non-small cell lung carcinomas.
    Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
    J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
    Ouyang N; Chen G; Ding J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
    Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretagogin is a new neuroendocrine marker in the human prostate.
    Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
    Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
    Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
    Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.
    Lantuéjoul S; Laverrière MH; Sturm N; Moro D; Frey G; Brambilla C; Brambilla E
    Hum Pathol; 2000 Apr; 31(4):415-21. PubMed ID: 10821486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
    Petrović M; Baskić D; Banković D; Ilić N
    Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I; Graziano SL
    J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
    Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of elevated serum chromogranin A levels.
    Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
    Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
    Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
    Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine lung structures and tumours: immunohistochemical study by specific markers.
    Mosca L; Barbareschi M; Mauri MF; Munguia-Barrera J; Frigo B; Muscarà M; Valentini L; Mariscotti C
    Histol Histopathol; 1988 Oct; 3(4):367-76. PubMed ID: 2980246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.